Astrazeneca (AZN) stock closed down 0.63%, but gained 9.9% in last month

From Nasdaq: 2025-03-06 18:15:12

In the latest trading session, Astrazeneca (AZN) closed at $77.47, down 0.63%, outperforming the S&P 500. The stock gained 9.9% in the last month, surpassing the Medical sector and S&P 500. Earnings per share (EPS) are projected to be $1.10 with revenue expected to reach $13.6 billion for the upcoming quarter.

Investors should watch for analyst revisions and utilize the Zacks Rank model. Astrazeneca currently holds a Zacks Rank of #4 (Sell) with a Forward P/E ratio of 17.36, below the industry average. The PEG ratio stands at 1.5, indicating potential growth. The Medical sector is ranked in the top 27% of all industries.

For just $1, access all Zacks’ picks, including Surprise Trader and Technology Innovators. Thousands have benefitted from this offer. Get acquainted with Zacks’ portfolio services and make informed investment decisions. Download 7 Best Stocks for the Next 30 Days and stay updated on stock-moving metrics.



Read more at Nasdaq: Astrazeneca (AZN) Stock Moves -0.63%: What You Should Know